We much appreciate the positive comments and interest concerning our study on the environmental and occupational risk factors of amyotrophic lateral sclerosis (ALS) [1]. As correctly noted by these authors, in our paper we already acknowledged some limitations they outline. They included recall bias, since exposure assessment relied on self-reporting using a questionnaire, as well as the small sample size influencing the low number of exposed subjects in such categories, including the subjects working in the agricultural sector, decreasing as a consequence the statistical precision of the estimate [2].
As regards occupational exposure to lead, we also assessed the period and the duration of occupational exposures, but we did not include in our paper the corresponding estimates for the high number of non-responders and the consequent uncertainties. We are now reporting such results: in particular, the analysis restricted only to subjects reporting the duration of occupational exposure to lead yielded an adjusted odds ratio (OR) of 7.48 (95% confidence interval (CI) 2.48 to 22.50), with a stronger association for subjects with longer (≥20 years) durations of exposure (Table 1) [3,4].
Based on the comment and the recently published findings on occupational solvent exposure and ALS risk, we are pleased to see the consistency of our findings with those of Dickerson et al. in the Danish population, and we strongly agree with the assertion of the opportunity to further investigate this important line of research [5]. In our population, in a new analysis restricted only to subjects reporting the duration of such exposure, we found a higher ALS risk (OR = 2.58, 95% CI 1.24 to 5.40) (Table 1). We also carried out an additional analysis, taking into account the duration of solvent exposure, which yielded a slightly stronger association for subjects with duration ≥20 years compared with ≥10 years (Table 1).
Overall, we agree about the need to emphasize the characteristics and limitations of our study, particularly with reference to the comparability of our findings with other studies and populations. In particular, the external validity of the findings of our or other studies may be influenced by the genetic background of the study participants, i.e., by the inclusion of ALS patients carrying specific gene mutations and/or the familial form of the disease, since these subjects may carry specific susceptibilities to chemicals [6,7]. Finally, we strongly agree that the environmental risk factors of ALS, and the exposure to chemicals, particularly including heavy metals [8,9] and selenium [10], as well as other physical and biological factors [11,12,13,14], definitely warrant further investigations, also taking into account the possible interactions between them, to be assessed through advanced data analysis tools [5,15,16].
Formal analysis: T.F. and M.V.; Writing—original draft: T.F. and M.V.; Writing—review and editing: all authors. All authors have read and agreed to the published version of the manuscript.
This work was supported by a grant “Dipartimenti di Eccellenza 2018–2022, MIUR, Italy” to the Department of Biomedical, Metabolic and Neural Sciences. The study was also supported by the Local Health Authority of Reggio Emilia. The funder had no role in the design, analysis or writing of this article.
We thank Stefania Moia from ‘Centro Regionale Esperto SLA’ of Novara for the support in the collection of data.
The authors declare no conflict of interest.
Odds ratio (OR) with 95% confidence interval (CI) of amyotrophic lateral sclerosis (ALS) risk according to occupational exposure to lead and solvents and exposure duration.
Occupational Exposure | Cases (y/n) | Controls (y/n) | OR a | OR b | (95% CI) |
---|---|---|---|---|---|
Lead | |||||
Any duration | 23/72 | 13/122 | 3.00 | 3.66 | (1.63–8.20) |
Without subjects not reporting duration | 17/72 | 5/122 | 5.76 | 7.48 | (2.48–22.50) |
Duration ≥10 years | 14/72 | 4/122 | 5.93 | 8.24 | (2.44–27.82) |
Duration ≥20 years | 9/72 | 2/122 | 7.62 | 11.60 | (2.29–58.81) |
Solvents | |||||
Any duration | 44/51 | 50/85 | 1.47 | 1.46 | (0.82–2.61) |
Without subjects not reporting duration | 27/51 | 19/85 | 2.37 | 2.58 | (1.24–5.40) |
Duration ≥10 years | 20/51 | 16/85 | 2.08 | 2.19 | (1.00–4.80) |
Duration ≥20 years | 11/51 | 9/85 | 2.04 | 2.39 | (0.89–6.46) |
a Crude model; b Model adjusted by sex, age and educational attainment.
References
1. Filippini, T.; Tesauro, M.; Fiore, M.; Malagoli, C.; Consonni, M.; Violi, F.; Iacuzio, L.; Arcolin, E.; Conti, O.G.; Cristaldi, A. et al. Environmental and occupational risk factors of amyotrophic lateral sclerosis: A population-based case-control study. Int. J. Environ. Res. Public Health; 2020; 17, 2882. [DOI: https://dx.doi.org/10.3390/ijerph17082882] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32331298]
2. Rothman, K.J.; Greenland, S. Planning study size based on precision rather than power. Epidemiology; 2018; 29, pp. 599-603. [DOI: https://dx.doi.org/10.1097/EDE.0000000000000876] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29912015]
3. Guidetti, D.; Bondavalli, M.; Sabadini, R.; Marcello, N.; Vinceti, M.; Cavalletti, S.; Marbini, A.; Gemignani, F.; Colombo, A.; Ferrari, A. et al. Epidemiological survey of amyotrophic lateral sclerosis in the province of Reggio Emilia, Italy: Influence of environmental exposure to lead. Neuroepidemiology; 1996; 15, pp. 301-312. [DOI: https://dx.doi.org/10.1159/000109920] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/8930943]
4. Vinceti, M.; Filippini, T.; Mandrioli, J.; Violi, F.; Bargellini, A.; Weuve, J.; Fini, N.; Grill, P.; Michalke, B. Lead, cadmium and mercury in cerebrospinal fluid and risk of amyotrophic lateral sclerosis: A case-control study. J. Trace Elem. Med. Biol.; 2017; 43, pp. 121-125. [DOI: https://dx.doi.org/10.1016/j.jtemb.2016.12.012] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28089071]
5. Dickerson, A.S.; Hansen, J.; Thompson, S.; Gredal, O.; Weisskopf, M.G. A mixtures approach to solvent exposures and amyotrophic lateral sclerosis: A population-based study in Denmark. Eur. J. Epidemiol.; 2020; 35, pp. 241-249. [DOI: https://dx.doi.org/10.1007/s10654-020-00624-5] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32193761]
6. Mandrioli, J.; Michalke, B.; Solovyev, N.; Grill, P.; Violi, F.; Lunetta, C.; Conte, A.; Sansone, V.A.; Sabatelli, M.; Vinceti, M. Elevated levels of selenium species in cerebrospinal fluid of amyotrophic lateral sclerosis patients with disease-associated gene mutations. Neurodegener. Dis.; 2017; 17, pp. 171-180. [DOI: https://dx.doi.org/10.1159/000460253] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28478440]
7. Violi, F.; Solovyev, N.; Vinceti, M.; Mandrioli, J.; Lucio, M.; Michalke, B. The study of levels from redox-active elements in cerebrospinal fluid of amyotrophic lateral sclerosis patients carrying disease-related gene mutations shows potential copper dyshomeostasis. Metallomics; 2020; 12, pp. 668-681. [DOI: https://dx.doi.org/10.1039/D0MT00051E] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32373852]
8. Cragg, J.J.; Cudkowicz, M.E.; Weisskopf, M.G. The role of environmental toxins in amyotrophic lateral sclerosis risk. JAMA Neurol.; 2016; 73, pp. 779-780. [DOI: https://dx.doi.org/10.1001/jamaneurol.2016.1038] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/27158795]
9. Weisskopf, M.G.; Morozova, N.; O’Reilly, E.J.; McCullough, M.L.; Calle, E.E.; Thun, M.J.; Ascherio, A. Prospective study of chemical exposures and amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry; 2009; 80, pp. 558-561. [DOI: https://dx.doi.org/10.1136/jnnp.2008.156976] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/19372290]
10. Vinceti, M.; Filippini, T.; Malagoli, C.; Violi, F.; Mandrioli, J.; Consonni, D.; Rothman, K.J.; Wise, L.A. Amyotrophic lateral sclerosis incidence following exposure to inorganic selenium in drinking water: A long-term follow-up. Environ. Res.; 2019; 179, 108742. [DOI: https://dx.doi.org/10.1016/j.envres.2019.108742]
11. Dickerson, A.S.; Hansen, J.; Kioumourtzoglou, M.A.; Specht, A.J.; Gredal, O.; Weisskopf, M.G. Study of occupation and amyotrophic lateral sclerosis in a Danish cohort. Occup. Environ. Med.; 2018; 75, pp. 630-638. [DOI: https://dx.doi.org/10.1136/oemed-2018-105110] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29941657]
12. Filippini, T.; Fiore, M.; Tesauro, M.; Malagoli, C.; Consonni, M.; Violi, F.; Arcolin, E.; Iacuzio, L.; Conti, O.G.; Cristaldi, A. et al. Clinical and lifestyle factors and risk of amyotrophic lateral sclerosis: A population-based case-control study. Int. J. Environ. Res. Public Health; 2020; 17, 857. [DOI: https://dx.doi.org/10.3390/ijerph17030857] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32019087]
13. Fiore, M.; Parisio, R.; Filippini, T.; Mantione, V.; Platania, A.; Odone, A.; Signorelli, C.; Pietrini, V.; Mandrioli, J.; Teggi, S. et al. Living near waterbodies as a proxy of cyanobacteria exposure and risk of amyotrophic lateral sclerosis: A population based case-control study. Environ. Res.; 2020; 186, 109530. [DOI: https://dx.doi.org/10.1016/j.envres.2020.109530] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32335431]
14. Gunnarsson, L.G.; Bodin, L. Occupational exposures and neurodegenerative diseases—A systematic literature review and meta-analyses. Int. J. Environ. Res. Public Health; 2019; 16, 337. [DOI: https://dx.doi.org/10.3390/ijerph16030337] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30691095]
15. Bellavia, A.; Valeri, L. Decomposition of the total effect in the presence of multiple mediators and interactions. Am. J. Epidemiol.; 2018; 187, pp. 1311-1318. [DOI: https://dx.doi.org/10.1093/aje/kwx355] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29140421]
16. Vinceti, M.; Fiore, M.; Signorelli, C.; Odone, A.; Tesauro, M.; Consonni, M.; Arcolin, E.; Malagoli, C.; Mandrioli, J.; Marmiroli, S. et al. Environmental risk factors for amyotrophic lateral sclerosis: Methodological issues in epidemiologic studies. Ann. Ig.; 2012; 24, pp. 407-415. [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23193897]
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Abstract
[...]we strongly agree that the environmental risk factors of ALS, and the exposure to chemicals, particularly including heavy metals [8,9] and selenium [10], as well as other physical and biological factors [11,12,13,14], definitely warrant further investigations, also taking into account the possible interactions between them, to be assessed through advanced data analysis tools [5,15,16]. Table Table 1 Odds ratio (OR) with 95% confidence interval (CI) of amyotrophic lateral sclerosis (ALS) risk according to occupational exposure to lead and solvents and exposure duration. Occupational Exposure Cases (y/n) Controls (y/n) OR a OR b (95% CI) Lead Any duration 23/72 13/122 3.00 3.66 (1.63–8.20) Without subjects not reporting duration 17/72 5/122 5.76 7.48 (2.48–22.50) Duration ≥10 years 14/72 4/122 5.93 8.24 (2.44–27.82) Duration ≥20 years 9/72 2/122 7.62 11.60 (2.29–58.81) Solvents Any duration 44/51 50/85 1.47 1.46 (0.82–2.61) Without subjects not reporting duration 27/51 19/85 2.37 2.58 (1.24–5.40) Duration ≥10 years 20/51 16/85 2.08 2.19 (1.00–4.80) Duration ≥20 years 11/51 9/85 2.04 2.39 (0.89–6.46) a Crude model; b Model adjusted by sex, age and educational attainment. Vinceti, M.; Filippini, T.; Mandrioli, J.; Violi, F.; Bargellini, A.; Weuve, J.; Fini, N.; Grill, P.; Michalke, B. Lead, cadmium and mercury in cerebrospinal fluid and risk of amyotrophic lateral sclerosis: A case-control study.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details










1 CREAGEN-Environmental, Genetic and Nutritional Epidemiology Research Center, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy;
2 Department of Biomedical, Surgical and Dental Sciences, University of Milan, 20122 Milan, Italy;
3 Department of Medical, Surgical Sciences and Advanced Technologies “G. F. Ingrassia”, Catania University, 95123 Catania, Italy;
4 CREAGEN-Environmental, Genetic and Nutritional Epidemiology Research Center, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy;
5 CREAGEN-Environmental, Genetic and Nutritional Epidemiology Research Center, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy;
6 Neurology Unit, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy;
7 ALS Centre Department of Neurology, ‘Maggiore della Carità’ University Hospital, 28100 Novara, Italy;
8 Neurological Rehabilitation Division, Policlinico San Marco di Zingonia, 24046 Zingonia (BG), Italy;
9 Neurology Unit, Department of Neuroscience, S. Agostino Estense Hospital, Azienda Ospedaliero Universitaria di Modena, 41126 Modena, Italy;
10 CREAGEN-Environmental, Genetic and Nutritional Epidemiology Research Center, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy;